Search

Your search keyword '"García, M. J."' showing total 812 results

Search Constraints

Start Over You searched for: Author "García, M. J." Remove constraint Author: "García, M. J."
812 results on '"García, M. J."'

Search Results

6. Selective Attention (SA) and Perceptual Inhibition (PI) Throughout the Lifespan.

9. P829 Clostridioides difficile infection in patients using vedolizumab and antiTNF: incidence and consequences (CDIFVEDO study of GETECCU)

10. P1117 Molecular and clinical characterization of metabolic associated steatotic liver disease in the setting of immune-mediated inflammatory diseases: a link with cancer risk in IBD?

11. P230 Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry

12. DOP08 A novel multiomic approach to unravel the mechanisms of action of biologics and tofacitinib in Inflammatory Bowel Disease

14. P033 Unrevealing new potential key mechanisms implicated in inflammatory bowel disease by multiomic approach

16. DOP22 Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine

17. Lumped and Distributed Parameter SPICE Models of TE Devices Considering Temperature Dependent Material Properties

22. Chaotic dynamics of electric-field domains in periodically driven superlattices

26. Valor Clínico de la Medición del Gasto Cardiaco por Bioimpedancia

27. Oceanographic variability in the northern shelf of the Iberian Peninsula, 1990-1999

28. P778 Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

30. P643 Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study

31. P675 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases

38. POS0997 CLINICAL FEATURES OF UVEITIS ASSOCIATED TO SPONDYLOARTHRITIS. SINGLE CENTER UNIVERSITY STUDY.

41. Prevalence of Dientamoeba fragilis and other intestinal protozoa from a swine farm at the Andean region of Colombia

42. Waste animal fats as feedstock for biodiesel production using non-catalytic supercritical alcohol transesterification: A perspective by the PRISMA methodology

44. Occupancy models reveal potential of conservation prioritization for Central American jaguars

45. AB0612 THE FRACTURE PREVENTION UNIT OF THE VIRGEN MACARENA HOSPITAL REDUCES THE GAP IN THE MANAGEMENT OF OP, PARTICULARLY IN MALES AND MEETS IOF/ESCEO QUALITY STANDARDS

47. Endogenous capital stock and depreciation in the United States.

48. Changes in bone mass in a child population with type 1 diabetes mellitus. Longitudinal study.

49. Thermodynamics and Kinetics of Micellization, including Solubilization

50. DOP78 Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD)

Catalog

Books, media, physical & digital resources